Search This Blog

Wednesday, July 31, 2019

United Therapeutics EPS beats by $0.89, beats on revenue

United Therapeutics (NASDAQ:UTHR): Q2 Non-GAAP EPS of $3.63 beats by $0.89; GAAP EPS of $4.66 beats by $2.20.
Revenue of $373.6M (-16.0% Y/Y) beats by $41.34M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)